Read + Share
Shi R, Farnsworth DA, Febres-Aldana CA, Chow JLM, et al. Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an
ILK-SFK-YAP signaling axis in lung adenocarcinoma. Oncogene 2025;44:2831-2849.
PMID: 40450112
|
 |
|
Shi R, Farnsworth DA, Febres-Aldana CA, Chow JLM, et al. Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an
ILK-SFK-YAP signaling axis in lung adenocarcinoma. Oncogene 2025;44:2831-2849.
PMID: 40450112
|
|
|
|